These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19598248)

  • 1. Role of microsomal epoxide hydrolase in methamphetamine-induced drug dependence in mice.
    Shin EJ; Bing G; Chae JS; Kim TW; Bach JH; Park DH; Yamada K; Nabeshima T; Kim HC
    J Neurosci Res; 2009 Dec; 87(16):3679-86. PubMed ID: 19598248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
    Bjorklund NL; Sorg BA; Schenk JO
    Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens.
    Wagstaff JD; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1996 Aug; 278(2):547-54. PubMed ID: 8768703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressive effects of trihexyphenidyl on methamphetamine-induced dopamine release as measured by in vivo microdialysis.
    Shimosato K; Nagao N; Watanabe S; Kitayama S
    Synapse; 2003 Jul; 49(1):47-54. PubMed ID: 12710014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of tissue plasminogen activator in the sensitization of methamphetamine-induced dopamine release in the nucleus accumbens.
    Fukakusa A; Nagai T; Mizoguchi H; Otsuka N; Kimura H; Kamei H; Kim HC; Nabeshima T; Takuma K; Yamada K
    J Neurochem; 2008 Apr; 105(2):436-44. PubMed ID: 18036193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An inducer for glial cell line-derived neurotrophic factor and tumor necrosis factor-alpha protects against methamphetamine-induced rewarding effects and sensitization.
    Niwa M; Nitta A; Yamada Y; Nakajima A; Saito K; Seishima M; Shen L; Noda Y; Furukawa S; Nabeshima T
    Biol Psychiatry; 2007 Apr; 61(7):890-901. PubMed ID: 17046726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of organic cation transporter-3 in methamphetamine disposition and its behavioral response in rats.
    Nakayama H; Kitaichi K; Ito Y; Hashimoto K; Takagi K; Yokoi T; Takagi K; Ozaki N; Yamamoto T; Hasegawa T
    Brain Res; 2007 Dec; 1184():260-9. PubMed ID: 17988657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-lasting change in brain dynamics induced by methamphetamine: enhancement of protein kinase C-dependent astrocytic response and behavioral sensitization.
    Narita M; Miyatake M; Shibasaki M; Tsuda M; Koizumi S; Narita M; Yajima Y; Inoue K; Suzuki T
    J Neurochem; 2005 Jun; 93(6):1383-92. PubMed ID: 15935054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of methamphetamine-induced sensitization and reward in matrix metalloproteinase-2 and -9-deficient mice.
    Mizoguchi H; Yamada K; Niwa M; Mouri A; Mizuno T; Noda Y; Nitta A; Itohara S; Banno Y; Nabeshima T
    J Neurochem; 2007 Mar; 100(6):1579-88. PubMed ID: 17348864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsomal epoxide hydrolase deletion enhances tyrosine hydroxylase phosphorylation in mice after MPTP treatment.
    Liu M; Hunter R; Nguyen XV; Kim HC; Bing G
    J Neurosci Res; 2008 Sep; 86(12):2792-801. PubMed ID: 18500758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methamphetamine-induced hyperactivity and behavioral sensitization in PACAP deficient mice.
    Fujii H; Ishihama T; Ago Y; Shintani N; Kakuda M; Hashimoto H; Baba A; Matsuda T
    Peptides; 2007 Sep; 28(9):1674-9. PubMed ID: 17658665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity.
    Nakajima A; Yamada K; Nagai T; Uchiyama T; Miyamoto Y; Mamiya T; He J; Nitta A; Mizuno M; Tran MH; Seto A; Yoshimura M; Kitaichi K; Hasegawa T; Saito K; Yamada Y; Seishima M; Sekikawa K; Kim HC; Nabeshima T
    J Neurosci; 2004 Mar; 24(9):2212-25. PubMed ID: 14999072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Piccolo as a regulator of behavioral plasticity and dopamine transporter internalization.
    Cen X; Nitta A; Ibi D; Zhao Y; Niwa M; Taguchi K; Hamada M; Ito Y; Ito Y; Wang L; Nabeshima T
    Mol Psychiatry; 2008 Apr; 13(4):349, 451-63. PubMed ID: 18195717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of tissue plasminogen activator in methamphetamine-related reward and sensitization.
    Nagai T; Noda Y; Ishikawa K; Miyamoto Y; Yoshimura M; Ito M; Takayanagi M; Takuma K; Yamada K; Nabeshima T
    J Neurochem; 2005 Feb; 92(3):660-7. PubMed ID: 15659235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-type voltage-dependent calcium channels facilitate acetylation of histone H3 through PKCĪ³ phosphorylation in mice with methamphetamine-induced place preference.
    Shibasaki M; Mizuno K; Kurokawa K; Ohkuma S
    J Neurochem; 2011 Sep; 118(6):1056-66. PubMed ID: 21781114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mithramycin protects against dopaminergic neurotoxicity in the mouse brain after administration of methamphetamine.
    Hagiwara H; Iyo M; Hashimoto K
    Brain Res; 2009 Dec; 1301():189-96. PubMed ID: 19748494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity.
    Itzhak Y; Gandia C; Huang PL; Ali SF
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1040-7. PubMed ID: 9495865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine.
    Cass WA
    J Pharmacol Exp Ther; 1997 Jan; 280(1):105-13. PubMed ID: 8996187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine.
    Zhang L; Kitaichi K; Fujimoto Y; Nakayama H; Shimizu E; Iyo M; Hashimoto K
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1381-93. PubMed ID: 16839653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginsenosides attenuate methamphetamine-induced behavioral side effects in mice via activation of adenosine A2A receptors: possible involvements of the striatal reduction in AP-1 DNA binding activity and proenkephalin gene expression.
    Shin EJ; Nabeshima T; Suh HW; Jhoo WK; Oh KW; Lim YK; Kim DS; Choi KH; Kim HC
    Behav Brain Res; 2005 Mar; 158(1):143-57. PubMed ID: 15680202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.